233 related articles for article (PubMed ID: 3137096)
1. Luteal dysfunction in ovulation induction: the role of repetitive human chorionic gonadotropin supplementation during the luteal phase.
Blumenfeld Z; Nahhas F
Fertil Steril; 1988 Sep; 50(3):403-7. PubMed ID: 3137096
[TBL] [Abstract][Full Text] [Related]
2. Early pregnancy wastage: the role of repetitive human chorionic gonadotropin supplementation during the first 8 weeks of gestation.
Blumenfeld Z; Ruach M
Fertil Steril; 1992 Jul; 58(1):19-23. PubMed ID: 1624004
[TBL] [Abstract][Full Text] [Related]
3. Influence of progesterone/estradiol ratio on luteal function for achieving pregnancy in gonadotropin therapy.
Kamada S; Kubota T; Aso T
Horm Res; 1992; 37 Suppl 1():59-63. PubMed ID: 1427631
[TBL] [Abstract][Full Text] [Related]
4. Comparison of leuprolide acetate and human chorionic gonadotropin for the induction of ovulation in clomiphene citrate-stimulated cycles.
Scott RT; Bailey SA; Kost ER; Neal GS; Hofmann GE; Illions EH
Fertil Steril; 1994 May; 61(5):872-9. PubMed ID: 8174724
[TBL] [Abstract][Full Text] [Related]
5. Luteal phase support with hCG does not improve fecundity rate in human menopausal gonadotropin-stimulated cycles.
Keenan JA; Moghissi KS
Obstet Gynecol; 1992 Jun; 79(6):983-7. PubMed ID: 1579327
[TBL] [Abstract][Full Text] [Related]
6. Luteal phase hyperprolactinemia during ovulation induction with human menopausal gonadotropins: incidence, recurrence, and effect on pregnancy rates.
Tippet PD; Simon JA; Rifka SM; Falk RJ
Obstet Gynecol; 1989 Apr; 73(4):613-6. PubMed ID: 2494621
[TBL] [Abstract][Full Text] [Related]
7. The importance of human chorionic gonadotropin support of the corpus luteum during human gonadotropin therapy in women with anovulatory infertility.
Messinis IE; Bergh T; Wide L
Fertil Steril; 1988 Jul; 50(1):31-5. PubMed ID: 3133249
[TBL] [Abstract][Full Text] [Related]
8. Corpus luteum function and pregnancy rates with clomiphene citrate therapy: comparison of human chorionic gonadotrophin-induced versus spontaneous ovulation.
Agarwal SK; Buyalos RP
Hum Reprod; 1995 Feb; 10(2):328-31. PubMed ID: 7769057
[TBL] [Abstract][Full Text] [Related]
9. Ovulation triggering in clomiphene citrate-stimulated cycles: human chorionic gonadotropin versus a gonadotropin releasing hormone agonist.
Schmidt-Sarosi C; Kaplan DR; Sarosi P; Essig MN; Licciardi FL; Keltz M; Levitz M
J Assist Reprod Genet; 1995 Mar; 12(3):167-74. PubMed ID: 8520180
[TBL] [Abstract][Full Text] [Related]
10. A short course of menotropin after clomiphene failure in infertile women with luteal phase defects.
Wu CH
J Reprod Med; 1989 Oct; 34(10):807-10. PubMed ID: 2507780
[TBL] [Abstract][Full Text] [Related]
11. Shortened luteal phase after ovulation induction with human menopausal gonadotropin and human chorionic gonadotropin.
Olson JL; Rebar RW; Schreiber JR; Vaitukaitis JL
Fertil Steril; 1983 Mar; 39(3):284-91. PubMed ID: 6402386
[TBL] [Abstract][Full Text] [Related]
12. Triggering of ovulation in human menopausal gonadotrophin-stimulated cycles: comparison between intravenously administered gonadotrophin-releasing hormone (100 and 500 micrograms), GnRH agonist (buserelin, 500 micrograms) and human chorionic gonadotrophin (10,000 IU).
Gerris J; De Vits A; Joostens M; Van Royen E
Hum Reprod; 1995 Jan; 10(1):56-62. PubMed ID: 7745071
[TBL] [Abstract][Full Text] [Related]
13. Sequential use of clomiphene citrate and human menopausal gonadotropin in ovulation induction.
Kistner RW
Fertil Steril; 1976 Jan; 27(1):72-82. PubMed ID: 1245245
[TBL] [Abstract][Full Text] [Related]
14. Luteal phase support in ovarian induction cycles using human chorionic gonadotropin or oral progestagens.
Zayed FF; El-Jallad MF; Al-Chalabi HA
Saudi Med J; 2003 Jan; 24(1):34-6. PubMed ID: 12590270
[TBL] [Abstract][Full Text] [Related]
15. Delaying human chorionic gonadotropin administration in human menopausal gonadotropin-induced cycles decreases successful in vitro fertilization of human oocytes.
Laufer N; DeCherney AH; Tarlatzis BC; Zuckerman AL; Polan ML; Dlugi AM; Graebe R; Barnea ER; Naftolin F
Fertil Steril; 1984 Aug; 42(2):198-203. PubMed ID: 6430722
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotrophin luteal support overcomes luteal phase inadequacy after gonadotrophin-releasing hormone agonist-induced ovulation in gonadotrophin-stimulated cycles.
Peñarrubia J; Balasch J; Fábregues F; Creus M; Casamitjana R; Ballescá JL; Puerto B; Vanrell JA
Hum Reprod; 1998 Dec; 13(12):3315-8. PubMed ID: 9886506
[TBL] [Abstract][Full Text] [Related]
17. Is the corpus luteum normal after ovulation induction?
Lenz S; Lindenberg S
J Clin Ultrasound; 1990; 18(3):155-9. PubMed ID: 2155933
[TBL] [Abstract][Full Text] [Related]
18. [Ovarian stimulation and corpus luteum function in human in vitro fertilization and embryo transfer].
Hara S
Nihon Sanka Fujinka Gakkai Zasshi; 1987 Nov; 39(11):2043-50. PubMed ID: 3123577
[TBL] [Abstract][Full Text] [Related]
19. Effect of disruption versus continuation of gonadotrophin-releasing agonist after human chorionic gonadotrophin administration on corpus luteum function in patients undergoing ovulation induction for in-vitro fertilization.
Valbuena D; Pellicer A; Guanes PP; Remohí J; Simón C
Hum Reprod; 1997 Oct; 12(10):2118-22. PubMed ID: 9402265
[TBL] [Abstract][Full Text] [Related]
20. Addition of human chorionic gonadotropin to clomiphene citrate ovulation induction therapy does not improve pregnancy outcomes and luteal function.
Yilmaz B; Kelekci S; Savan K; Oral H; Mollamahmutoglu L
Fertil Steril; 2006 Mar; 85(3):783-6. PubMed ID: 16500364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
